BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26074429)

  • 21. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
    World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review.
    Al-Mufti F; Amuluru K; Changa A; Lander M; Patel N; Wajswol E; Al-Marsoummi S; Alzubaidi B; Singh IP; Nuoman R; Gandhi C
    Neurosurg Focus; 2017 Nov; 43(5):E14. PubMed ID: 29088959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed ischemic neurologic deficit with vasospasm in aneurysmal subarachnoid hemorrhage after negative post-bleed day 7 angiography.
    Winslow N; Ehsan M; Klopfenstein J
    Clin Neurol Neurosurg; 2022 Sep; 220():107353. PubMed ID: 35835022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Kumar G; Shahripour RB; Harrigan MR
    J Neurosurg; 2016 May; 124(5):1257-64. PubMed ID: 26495942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
    Ko NU; Rajendran P; Kim H; Rutkowski M; Pawlikowska L; Kwok PY; Higashida RT; Lawton MT; Smith WS; Zaroff JG; Young WL
    Stroke; 2008 Apr; 39(4):1103-8. PubMed ID: 18309169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TCD hyperemia index to detect vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
    Kim Y; Mehta A; Nair R; Felbaum DR; Mai JC; Armonda RA; Chang JJ
    J Neuroimaging; 2023; 33(5):725-730. PubMed ID: 37291461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.
    Lanterna LA; Rigoldi M; Tredici G; Biroli F; Cesana C; Gaini SM; Dalprà L
    Neurology; 2005 Apr; 64(7):1238-44. PubMed ID: 15824354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-early angiographic vasospasm associated with delayed cerebral ischemia and infarction following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Roh D; Lahiri S; Meyers E; Witsch J; Frey HP; Dangayach N; Falo C; Mayer SA; Agarwal S; Park S; Meyers PM; Connolly ES; Claassen J; Schmidt JM
    J Neurosurg; 2017 May; 126(5):1545-1551. PubMed ID: 27231975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
    J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.
    Vergouwen MD; Vermeulen M; Coert BA; Stroes ES; Roos YB
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1761-70. PubMed ID: 18628782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review.
    Jabbarli R; Pierscianek D; Darkwah Oppong M; Sato T; Dammann P; Wrede KH; Kaier K; Köhrmann M; Forsting M; Kleinschnitz C; Roos A; Sure U
    Neurosurg Rev; 2020 Jun; 43(3):825-833. PubMed ID: 30306357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haptoglobin phenotype predicts cerebral vasospasm and clinical deterioration after aneurysmal subarachnoid hemorrhage.
    Ohnishi H; Iihara K; Kaku Y; Yamauchi K; Fukuda K; Nishimura K; Nakai M; Satow T; Nakajima N; Ikegawa M
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):520-6. PubMed ID: 23498376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of specific age groups with a high risk for developing cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
    Neurosurg Rev; 2016 Jul; 39(3):429-36. PubMed ID: 26940102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.
    Heinsberg LW; Arockiaraj AI; Crago EA; Ren D; Shaffer JR; Sherwood PR; Sereika SM; Weeks DE; Conley YP
    Neurocrit Care; 2020 Apr; 32(2):550-563. PubMed ID: 31346934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment modality and vasospasm after aneurysmal subarachnoid hemorrhage.
    Gross BA; Rosalind Lai PM; Frerichs KU; Du R
    World Neurosurg; 2014 Dec; 82(6):e725-30. PubMed ID: 23954735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.
    Grossen AA; Ernst GL; Bauer AM
    Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic Treatment of Asymptomatic Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage for the Prevention of Delayed Cerebral Ischemia.
    Rebeiz T; Sabirov T; Wanchoo S; White TG; Da Silva I; Stefanov DG; Temes RE
    World Neurosurg; 2022 Oct; 166():e135-e139. PubMed ID: 35787959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.
    Collignon FP; Friedman JA; Piepgras DG; Pichelmann MA; McIver JI; Toussaint LG; McClelland RL
    Neurocrit Care; 2004; 1(4):441-8. PubMed ID: 16174947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.